동종골이식편 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global bone allografts market size is expected to reach USD 4.07 Billion in 2034 from USD 2.52 Billion in 2025, growing at a CAGR of 5.48 during 2026-2034.This market is experiencing steady growth as orthopedic procedures, spinal surgeries, and reconstructive treatments continue increasing worldwide. Bone allografts provide effective solutions for repairing skeletal defects, supporting bone regeneration, and improving surgical outcomes without requiring additional bone harvesting from patients. Rising prevalence of musculoskeletal disorders, increasing sports injuries, and expanding aging populations are encouraging greater adoption of bone grafting procedures across healthcare systems.

Healthcare providers are increasingly utilizing processed and sterilized allograft materials that offer improved safety, biocompatibility, and structural support. Advances in tissue preservation, regenerative medicine, and biologically enhanced graft materials are improving clinical performance and patient recovery. Growing investments in orthopedic research, trauma care, and minimally invasive surgical techniques are creating favorable opportunities for market expansion. Improved healthcare infrastructure in developing regions is also supporting increased procedure volumes.

The future outlook remains promising as regenerative medicine and orthopedic innovation continue advancing. Three-dimensional printing, tissue engineering, and bioactive graft technologies will improve treatment outcomes and expand clinical applications. Rising demand for joint replacement procedures, spinal fusion surgeries, and trauma reconstruction will strengthen long-term market growth. Continuous research and healthcare investments will support the evolution of advanced bone allograft solutions.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product

• Structural Allografts
• Demineralized Bone Matrix (DBM)
• Cellular Bone Matrices (CBM)
• Machined Allografts
• Others

By Application

• Spinal Fusion
• Trauma & Long Bone
• Joint Reconstruction
• Craniomaxillofacial
• Dental
• Foot & Ankle
• Sports Medicine

By End User

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Specialty Clinics/Dental Clinics

COMPANIES PROFILED

• Zimmer Biomet, Medtronic, Stryker, Smith+Nephew, Lynch Biologics, Biomatlante, Johnson & Johnson, Royal Biologics, Baxter International, Xtant Medical, NovaBone Products, Exactech, LifeNet Health, BioHorizons, Globus Medical, RTI Surgical, Geistlich Pharma, MegaGen, Novadip, Mesoblast, Alphatec Spine, Institut Straumann, NuVasive

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BONE ALLOGRAFTS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Structural Allografts Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Demineralized Bone Matrix (DBM) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Cellular Bone Matrices (CBM) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Machined Allografts Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BONE ALLOGRAFTS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Spinal Fusion Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Trauma & Long Bone Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Joint Reconstruction Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Craniomaxillofacial Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Dental Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Foot & Ankle Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Sports Medicine Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BONE ALLOGRAFTS MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Ambulatory Surgical Centers (ASCs) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Specialty Clinics/Dental Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BONE ALLOGRAFTS MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Application
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Application
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Application
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Application
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Application
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL BONE ALLOGRAFTS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Zimmer Biomet
  • 9.2.2 Medtronic
  • 9.2.3 Stryker
  • 9.2.4 Smith+Nephew
  • 9.2.5 Lynch Biologics
  • 9.2.6 Biomatlante
  • 9.2.7 Johnson & Johnson
  • 9.2.8 Royal Biologics
  • 9.2.9 Baxter International
  • 9.2.10 Xtant Medical
  • 9.2.11 NovaBone Products
  • 9.2.12 Exactech
  • 9.2.13 LifeNet Health
  • 9.2.14 BioHorizons
  • 9.2.15 Globus Medical
  • 9.2.16 RTI Surgical
  • 9.2.17 Geistlich Pharma
  • 9.2.18 MegaGen
  • 9.2.19 Novadip
  • 9.2.20 Mesoblast
  • 9.2.21 Alphatec Spine
  • 9.2.22 Institut Straumann
  • 9.2.23 NuVasive